MM Healthcare group or EB generalist programme? (life science background aiming for HC buyside)

I have offers from an MM IB specifically in their healthcare team and an EB but the analyst programme is generalist. I come from an advanced life science degree background and looking to leverage that to aim for HC groups on the buyside whether that is PE or HF. Which of the two would best position me for that? The MM would obviously allow me to gain valuable HC experience but I am hesitant to pigeon hole myself into the MM space and likely close off HFs. Any thoughts appreciated.

18 Comments
 

Top MM HC are Roths and Jef, anything else not worth it but again you'll provably need to lateral elsewhere for top exits. Is the Generalist role with a firm that does rotations / has strong HC practice? If so then take EB (except Moelis) and you can get HC exposure from there and then potentially lateral to HC groups as senior analyst / junior Assoc. Niche buy side roles in life sciences would target HC groups so if that's what you want you need to be at one to have decent chances.

 
Most Helpful

If you're trying to get into HC buyside on the life science side, I'd like to add that MTS Health Partners is worth checking out. I don't think they have any openings yet but a handful of their analysts in recent years have exited to life science buyside.

Always thought very highly of most of the bankers I've interacted there. One of my college buddies runs the commercialization side of his biotech startup and seems to think highly of them (not an official client but has spoken / interacted with MTS before).

 

Hic explicabo eum dolor et. In quis cupiditate tenetur rem. Ea omnis inventore dolores labore. Hic voluptas ipsa ut rerum autem.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 01 98.3%
  • BMO Capital Markets 13 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (15) $434
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”